Vivien Bonert

3.8k total citations · 1 hit paper
43 papers, 2.2k citations indexed

About

Vivien Bonert is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Epidemiology. According to data from OpenAlex, Vivien Bonert has authored 43 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Endocrinology, Diabetes and Metabolism, 18 papers in Surgery and 5 papers in Epidemiology. Recurrent topics in Vivien Bonert's work include Pituitary Gland Disorders and Treatments (36 papers), Growth Hormone and Insulin-like Growth Factors (35 papers) and Adrenal and Paraganglionic Tumors (15 papers). Vivien Bonert is often cited by papers focused on Pituitary Gland Disorders and Treatments (36 papers), Growth Hormone and Insulin-like Growth Factors (35 papers) and Adrenal and Paraganglionic Tumors (15 papers). Vivien Bonert collaborates with scholars based in United States, France and Spain. Vivien Bonert's co-authors include Шломо Мелмед, John D. Carmichael, David L. Kleinberg, David M. Cook, Beverly M. K. Biller, Stavros Stavrou, James Mirocha, Mark E. Molitch, Annamaria Colao and Odelia Cooper and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Journal of neurosurgery and Neurosurgery.

In The Last Decade

Vivien Bonert

42 papers receiving 2.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Guidelines of the Pituitary Society for the diagnosis and management of prolactinomas

2006 533 citations Felipe F. Casanueva, Mark E. Molitch et al. Clinical Endocrinology profile →

Peers

Vivien Bonert

EDM

SURGE

EPIDE

GENET

Antonella Giampietro Italy

Bernardo Liberman Brazil

Gaetana Cerbone Italy

Francesca Pecori Giraldi Italy

Patrick Pétrossians Belgium

Georgia Ntali Greece

Václav Hána Czechia

C Rajasoorya Singapore

Ludovica F. S. Grasso Italy

Yutaka Oki Japan

Antonella Giampietro Italy

Vivien Bonert

1.5k ×0.7

EDM

491 ×0.6

SURGE

339 ×1.0

EPIDE

240 ×1.0

GENET

233 ×1.2

Citations per year, relative to Vivien Bonert Vivien Bonert (= 1×) peers Antonella Giampietro

Countries citing papers authored by Vivien Bonert

Since Specialization

Citations

This map shows the geographic impact of Vivien Bonert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vivien Bonert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vivien Bonert more than expected).

Fields of papers citing papers by Vivien Bonert

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vivien Bonert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vivien Bonert. The network helps show where Vivien Bonert may publish in the future.

Co-authorship network of co-authors of Vivien Bonert

This figure shows the co-authorship network connecting the top 25 collaborators of Vivien Bonert. A scholar is included among the top collaborators of Vivien Bonert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vivien Bonert. Vivien Bonert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Shah, Shruti, et al.. (2025). Patient perspectives on acromegaly disease burden: insights from a community meeting. Frontiers in Endocrinology. 16. 1516131–1516131. 2 indexed citations

Cooper, Odelia, Vivien Bonert, Ning‐Ai Liu, et al.. (2023). Fluid Restriction Reduces Delayed Hyponatremia and Hospital Readmissions After Transsphenoidal Surgery. The Journal of Clinical Endocrinology & Metabolism. 108(8). e623–e633. 7 indexed citations

Cooper, Odelia, Vivien Bonert, Ning‐Ai Liu, & Adam N. Mamelak. (2021). Treatment of Aggressive Pituitary Adenomas: A Case-Based Narrative Review. Frontiers in Endocrinology. 12. 725014–725014. 8 indexed citations

Kuo, Michael, M. Marcel Maya, Vivien Bonert, & Шломо Мелмед. (2020). Prospective Evaluation of Incidental Pituitary Imaging Findings in the Sella Turcica. Journal of the Endocrine Society. 5(2). bvaa186–bvaa186. 14 indexed citations

Bonert, Vivien. (2020). Do nothing but observe microprolactinomas: when and how to replace sex hormones?. Pituitary. 23(3). 307–313. 12 indexed citations

Cooper, Odelia, Vivien Bonert, Jeremy Rudnick, et al.. (2020). EGFR/ErbB2-Targeting Lapatinib Therapy for Aggressive Prolactinomas. The Journal of Clinical Endocrinology & Metabolism. 106(2). e917–e925. 49 indexed citations

Bonert, Vivien, John D. Carmichael, Zengru Wu, et al.. (2017). Discordance between mass spectrometry and immunometric IGF-1 assay in pituitary disease: a prospective study. Pituitary. 21(1). 65–75. 21 indexed citations

Carmichael, John D., Michael S. Broder, Dasha Cherepanov, et al.. (2017). Long-term treatment outcomes of acromegaly patients presenting biochemically-uncontrolled at a tertiary pituitary center. BMC Endocrine Disorders. 17(1). 49–49. 9 indexed citations

Geer, Eliza B., Alejandro Ayala, Vivien Bonert, et al.. (2017). Follow-up intervals in patients with Cushing’s disease: recommendations from a panel of experienced pituitary clinicians. Pituitary. 20(4). 422–429. 7 indexed citations

10.

Fleseriu, Maria, Luis M. Tumialán, Vivien Bonert, et al.. (2016). Congress of Neurological Surgeons Systematic Review and Evidence-Based Guideline for Pretreatment Endocrine Evaluation of Patients With Nonfunctioning Pituitary Adenomas. Neurosurgery. 79(4). E527–E529. 31 indexed citations

11.

Bonert, Vivien, John D. Carmichael, Adam N. Mamelak, et al.. (2014). A Protracted and Affressive Variant of Lymphocytic Hypophysitis with Mammillary Body Involvement and Cognitive Dysfunction. Endocrine Practice. 20(11). 225–229. 2 indexed citations

12.

Cuevas-Ramos, Daniel, John D. Carmichael, Odelia Cooper, et al.. (2014). A Structural and Functional Acromegaly Classification. The Journal of Clinical Endocrinology & Metabolism. 100(1). 122–131. 92 indexed citations

13.

Cooper, Odelia, Adam N. Mamelak, Serguei Bannykh, et al.. (2013). Prolactinoma ErbB receptor expression and targeted therapy for aggressive tumors. Endocrine. 46(2). 318–327. 63 indexed citations

14.

Biller, Beverly M. K., Annamaria Colao, Stephan Petersenn, Vivien Bonert, & Marco Boscaro. (2010). Prolactinomas, Cushing's disease and acromegaly: debating the role of medical therapy for secretory pituitary adenomas. BMC Endocrine Disorders. 10(1). 10–10. 48 indexed citations

15.

Bonert, Vivien. (2009). 4 Diagnostic challenges in acromegaly: a case-based review. Best Practice & Research Clinical Endocrinology & Metabolism. 23. S23–S30. 6 indexed citations

16.

Carmichael, John D., Vivien Bonert, James Mirocha, & Шломо Мелмед. (2008). The Utility of Oral Glucose Tolerance Testing for Diagnosis and Assessment of Treatment Outcomes in 166 Patients with Acromegaly. The Journal of Clinical Endocrinology & Metabolism. 94(2). 523–527. 113 indexed citations

17.

Carmichael, John D. & Vivien Bonert. (2007). Medical therapy: Options and uses. Reviews in Endocrine and Metabolic Disorders. 9(1). 71–81. 7 indexed citations

18.

Casanueva, Felipe F., Mark E. Molitch, Janet Schlechte, et al.. (2006). Guidelines of the Pituitary Society for the diagnosis and management of prolactinomas. Clinical Endocrinology. 65(2). 265–273. 533 indexed citations breakdown →

19.

Bonert, Vivien & Шломо Мелмед. (2006). Acromegaly with moderate hyperprolactinemia caused by an intrasellar macroadenoma. Nature Clinical Practice Endocrinology & Metabolism. 2(7). 408–412. 7 indexed citations

20.

Sesmilo, Gemma, Wesley P. Fairfield, Laurence Katznelson, et al.. (2002). Cardiovascular Risk Factors in Acromegaly before and after Normalization of Serum IGF-I Levels with the GH Antagonist Pegvisomant. The Journal of Clinical Endocrinology & Metabolism. 87(4). 1692–1699. 96 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact